SCHEMBL8398489

SCHEMBL8398489

CCc1ccccc1-n1cnc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.63
ALDH1A1 P00352 2/20 0.63
LMNA P02545 1/20 0.63
HCAR1 Q9BXC0 1/20 0.57
HTT P42858 3/20 0.53
KDM4E B2RXH2 1/20 0.52
USP2 O75604 1/20 0.52
CASP1 P29466 1/20 0.52
CASP7 P55210 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.49
FGFR1 P11362 2/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417306 0.83 HTT (0.73) ALDH1A1HTTPOLBFGFR1MKNK1
SCHEMBL7211152 0.82 HTT (0.49) HPGDALDH1A1LMNAHTTPOLB
SCHEMBL7210786 0.82 HTT (0.49) HPGDALDH1A1LMNAHCAR1HTT
SCHEMBL30026657 0.79 PKM (0.53) HPGDALDH1A1LMNAHTTKDM4E
SCHEMBL12138417 0.79 HTT (0.56) HPGDHCAR1HTTKDM4EPOLB
SCHEMBL29830215 0.79 HTT (0.56) HPGDHCAR1HTTKDM4EPOLB
SCHEMBL541062 0.79 HTT (0.45) HPGDALDH1A1LMNAHTTPOLB
SCHEMBL23266636 0.78 HTT (0.60) ALDH1A1HTTPOLBFGFR1MKNK1
SCHEMBL11793167 0.77 MAPT (0.48) HPGDALDH1A1LMNAHTTPOLB
SCHEMBL23840256 0.77 HTT (0.58) ALDH1A1HTTPOLBFGFR1MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100478031-C The use of substituted tetracyclic imidazole derivatives as anti-histaminics JANSSEN PHARMACEUTICA NV (BE) 2009-04-15 CN disclosed
CN-1895673-A The use of substituted tetracyclic imidazole derivatives as anti-histaminics JANSSEN PHARMACEUTICA NV (BE) 2007-01-17 CN disclosed
EP-0619333-B1 Process for coating metals ATOTECH DEUTSCHLAND GMBH (DE) 1999-06-02 EP disclosed
EP-0794847-B1 PROCESS FOR BONDING WIRES TO OXIDATION-SENSITIVE METAL SUBSTRATES WHICH CAN BE SOLDERED ATOTECH DEUTSCHLAND GMBH (DE) 1998-07-22 EP disclosed
EP-0794847-A1 PROCESS FOR BONDING WIRES TO OXIDATION-SENSITIVE METAL SUBSTRATES WHICH CAN BE SOLDERED ATOTECH Deutschland GmbH (DE) 1997-09-17 EP disclosed
WO-1996016768-A1 PROCESS FOR BONDING WIRES TO OXIDATION-SENSITIVE METAL SUBSTRATES WHICH CAN BE SOLDERED ATOTECH DEUTSCHLAND GMBH (DE) 1996-06-06 WO disclosed
EP-0619333-A2 Process for coating metals ATOTECH Deutschland GmbH (DE) 1994-10-12 EP disclosed